-
公开(公告)号：US5432193A
公开(公告)日：1995-07-11
申请号：US61373
申请日：1993-05-14
Applicant: Guy T. Carter , Gerhard Schlingmann , David P. Labeda , Joseph J. Goodman
Inventor： Guy T. Carter , Gerhard Schlingmann , David P. Labeda , Joseph J. Goodman
IPC: C07D407/14 , C07H19/01 , A61K31/35
CPC classification number: C07D407/14 , C07H19/01
Abstract: This invention relates to antibiotic LL-D37187.alpha. derived from the microorganism Streptomyces which is useful as an antibacterial agent.
Abstract translation: 本发明涉及可用作抗菌剂的来自微生物链霉菌的抗生素LL-D37187α。
-
公开(公告)号：US4578468A
公开(公告)日：1986-03-25
申请号：US593159
申请日：1984-03-26
Applicant: Guy T. Carter , Donald B. Borders , Joseph J. Goodman , David P. Labeda
Inventor： Guy T. Carter , Donald B. Borders , Joseph J. Goodman , David P. Labeda
IPC: A23K20/195 , A61K31/47 , A61P33/00 , A61P33/02 , C07D319/00 , C07D491/16 , C12P17/18 , C12R1/03 , C07D498/12
CPC classification number: C07D491/16 , A23K20/195 , C12P17/188 , C12R1/03
Abstract: Antibiotic LL-D42067.beta. derived by aerobic fermentation of the microorganism Actinomadura madurae subspecies simaoensis NRRL 15734, useful as an antibacterial and antiparasitic agent.
Abstract translation: 抗生素LL-D42067通过有氧发酵得到的微生物Actinomadura madurae亚种simaoensis NRRL 15734，可用作抗菌和抗寄生虫剂。
-
3.发明授权Subspecies of Micromonospora citrea which produces antibiotic LL-E19085 alpha 失效生产抗生素LL-E19085 ALPHA的MICROMONOSPORA CITREA的替代品
公开(公告)号：US5223430A
公开(公告)日：1993-06-29
申请号：US783582
申请日：1991-10-28
Applicant: Guy T. Carter , Joseph J. Goodman , David P. Labeda
Inventor： Guy T. Carter , Joseph J. Goodman , David P. Labeda
IPC: A23K20/195 , C07D498/14 , C12P17/18
CPC classification number: C07D498/14 , A23K20/195 , C12P17/188 , C12R1/29 , Y10S435/867
Abstract: This disclosure describes novel antibacterial agents designated LL-E10985.alpha., LL-E19085.beta., LL-E19085.gamma., LL-E19085.zeta. and LL-E19085.eta., having the structure: ##STR1## their production by aerobic fermentation of a new subspecies of Micromonospora citrea NRRL 18351 and mutants thereof, and the isolation and purification thereof.
Abstract translation: 本公开描述了称为LL-E10985α，LL-E19085β，LL-E19085γ，LL-E19085ζ和LL-E19085等的新型抗菌剂，具有以下结构：其通过需氧发酵的新亚种小单孢菌 柠檬酸NRRL 18351及其突变体，并进行分离和纯化。
-
公开(公告)号：US5096907A
公开(公告)日：1992-03-17
申请号：US639496
申请日：1991-01-09
Applicant: Guy T. Carter , Joseph J. Goodman , David P. Labeda
Inventor： Guy T. Carter , Joseph J. Goodman , David P. Labeda
IPC: A23K20/195 , C07D498/14 , C12P17/18
CPC classification number: C07D498/14 , A23K20/195 , C12P17/188 , Y10S435/867
Abstract: This disclosure describes novel antibacterial agents designated LL-E10985.alpha., LL-E19085.beta., LL-E19085.gamma., LL-E19085.gamma. and LL-E19085.zeta., having the structure: ##STR1## their production by aerobic fermentation of a new subspecies of Micromonospora citrea NRRL 18351 and mutants thereof, and the isolation and purification thereof.
Abstract translation: 本公开描述了新的抗菌剂，其命名为LL-E10985α，LL-E19085β，LL-E19085γ，LL-E19085γ和LL-E19085ζ，具有以下结构：其通过需氧发酵的新亚种小单孢菌 柠檬酸NRRL 18351及其突变体，并进行分离和纯化。
-
公开(公告)号：US4859598A
公开(公告)日：1989-08-22
申请号：US820048
申请日：1986-01-21
Applicant: Guy T. Carter , Donald B. Borders , Joseph J. Goodman , David P. Labeda
Inventor： Guy T. Carter , Donald B. Borders , Joseph J. Goodman , David P. Labeda
IPC: A23K20/195 , C07D491/16 , C12P17/18
CPC classification number: C07D491/16 , A23K20/195 , C12P17/188 , C12R1/03 , Y10S435/825
Abstract: Antibiotic LL-D42067.beta. derived by aerobic fermentation of the microorganism Actinomadura madurae subspecies simaoensis NRRL 15734, useful as an antibacterial and antiparasitic agent.
Abstract translation: 抗生素LL-D42067通过有氧发酵得到的微生物Actinomadura madurae亚种simaoensis NRRL 15734，可用作抗菌和抗寄生虫剂。
-
Patent Agency Ranking
公开(公告)号：US4407946A
公开(公告)日：1983-10-04
申请号：US313849
申请日：1981-10-22
Applicant: David P. Labeda , John H. E. J. Martin , Joseph J. Goodman
Inventor： David P. Labeda , John H. E. J. Martin , Joseph J. Goodman
CPC classification number: C07H19/01 , C12P19/60 , C12R1/03 , Y10S435/825 , Y10S435/875
Abstract: This invention relates to a novel process for the production of antibiotic X-14868A using the novel microorganism Antinomadura yumaense sp. nov.
Abstract translation: 本发明涉及使用新型微生物Antinomadura yumaense sp。生产抗生素X-14868A的新方法。 nov。
-
公开(公告)号：US4774184A
公开(公告)日：1988-09-27
申请号：US765418
申请日：1985-08-14
Applicant: Taikwang M. Lee , Donald B. Borders , Joseph J. Goodman , Raymond T. Testa , William M. Maiese , David P. Labeda
Inventor： Taikwang M. Lee , Donald B. Borders , Joseph J. Goodman , Raymond T. Testa , William M. Maiese , David P. Labeda
IPC: A23K20/195 , C07D491/16 , C12P17/18 , C12P17/16 , C12N1/20 , C12R1/03
CPC classification number: C07D491/16 , A23K20/195 , C12P17/188 , C12R1/03 , Y10S435/825
Abstract: The invention is a process for the production by fermentation of the antibacterial and antiparasitic agents designated LL-D42067.alpha., to methods for its recovery and concentration from crude solutions and to processes for its purification. The invention includes within its scope the biologically pure culture of the antibiotic.
Abstract translation: 本发明是通过发酵生产名为LL-D42067α的抗细菌剂和抗寄生虫剂的方法，用于从粗溶液中回收和浓缩的方法及其纯化方法。 本发明在其范围内包括抗生素的生物学纯培养。
-
公开(公告)号：US4628046A
公开(公告)日：1986-12-09
申请号：US506170
申请日：1983-06-20
Applicant: David P. Labeda , Joseph J. Goodman , John H. E. J. Martin, deceased
Inventor： David P. Labeda , Joseph J. Goodman , John H. E. J. Martin, deceased
CPC classification number: C07H19/01 , C12P19/44 , C12P19/445 , C12R1/465
Abstract: This disclosure describes a new antibacterial agent designated LL-C23201.delta., produced in a microbiological fermentation under controlled conditions using a new strain of Streptomyces olivaceo-griseus, sp. nov. and mutants thereof. This new antibacterial agent is active against a variety of microorganisms and thus is useful in inhibiting the growth of such bacteria wherever they may be found.
Abstract translation: 本公开描述了一种称为LL-C23201δ的新的抗菌剂，其在微生物发酵中在受控条件下使用新的菌株Streptomyces olivaceo-griseus，sp。 nov。 及其突变体。 这种新的抗菌剂对各种微生物具有活性，因此可用于抑制这些细菌的生长。
-
公开(公告)号：US4608343A
公开(公告)日：1986-08-26
申请号：US739334
申请日：1985-05-30
Applicant: David P. Labeda , Joseph J. Goodman , Donald B. Borders , Raymond T. Testa , John H. E. J. Martin, deceased
Inventor： David P. Labeda , Joseph J. Goodman , Donald B. Borders , Raymond T. Testa , John H. E. J. Martin, deceased
CPC classification number: C12P1/06
Abstract: This disclosure describes four new antibacterial agents designated LL-C08078.alpha..sub.1, LL-C08078.alpha..sub.2, LL-C08078.alpha..sub.3 and LL-C08078.beta. produced in a microbiological fermentation under controlled conditions using a new strain of a new species of the genus Streptomyces called Streptomyces majorciensis Labeda, sp. nov., and mutants thereof. These new antibacterial agents are active against a variety of microorganisms and thus are useful in inhibiting the growth of such bacteria wherever they may be found. In addition, these agents are active as growth promotants in warm-blooded animals.
Abstract translation: 本公开描述了在受控条件下使用新型链霉菌属的新菌株在微生物发酵中产生的四种新的抗菌剂，称为LL-C08078α1，LL-C08078α2，LL-C08078α3和LL-C08078ββ 称为Streptomyces majorciensis Labeda，sp。 nov。及其突变体。 这些新的抗菌剂对各种微生物具有活性，因此可用于抑制这些细菌的生长。 此外，这些试剂在温血动物中作为生长促进剂是有活性的。
-
公开(公告)号：US4551533A
公开(公告)日：1985-11-05
申请号：US593160
申请日：1984-03-26
Applicant: Taikwang M. Lee , Donald B. Borders , Joseph J. Goodman , Raymond T. Testa , William M. Maiese , David P. Labeda
Inventor： Taikwang M. Lee , Donald B. Borders , Joseph J. Goodman , Raymond T. Testa , William M. Maiese , David P. Labeda
IPC: A23K20/195 , C07D491/16 , C12P17/18 , C07D521/00 , C12N1/20 , C12R1/03
CPC classification number: C07D491/16 , A23K20/195 , C12P17/188 , C12R1/03 , Y10S435/825
Abstract: Antibiotic LL-D42067.alpha. derived by aerobic fermentation of the microorganism Actinomadura madurae subspecies simaoensis NRRL 15734, useful as an antibacterial and antiparasitic agent.
Abstract translation: 抗生素LL-D42067α是通过有氧发酵的微生物Actinomadura madurae亚种simaoensis NRRL 15734得到的，可用作抗菌和抗寄生虫剂。
-
-
-
-
-
-
-
-
-
Search Results
21
records
(took 0.025 seconds)
